HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fergus J Couch Selected Research

Galectin 3 (LGALS3)

7/2021N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors.
12/2008Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fergus J Couch Research Topics

Disease

155Breast Neoplasms (Breast Cancer)
11/2022 - 02/2002
117Neoplasms (Cancer)
06/2022 - 02/2004
23Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2004
15Triple Negative Breast Neoplasms
06/2022 - 04/2013
8Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 01/2005
6Endometrial Neoplasms (Endometrial Cancer)
01/2021 - 10/2015
5Genetic Risk Score
01/2021 - 01/2015
5Fanconi Anemia (Fanconi's Anemia)
10/2014 - 04/2005
4Prostatic Neoplasms (Prostate Cancer)
11/2022 - 11/2006
4Carcinogenesis
01/2018 - 12/2011
4Familial Breast Cancer
11/2017 - 09/2009
3Neoplasm Metastasis (Metastasis)
01/2022 - 11/2014
3Noninfiltrating Intraductal Carcinoma (DCIS)
10/2021 - 02/2016
3Adenocarcinoma
01/2018 - 05/2005
3Hypersensitivity (Allergy)
11/2015 - 04/2013
3Carcinoma (Carcinomatosis)
07/2015 - 02/2008
3Chromosomal Instability (Chromosome Stability)
07/2011 - 01/2010
2Amenorrhea
01/2021 - 10/2019
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 09/2009
2Disease Progression
01/2020 - 03/2013
2Obesity
02/2019 - 01/2018
2Endometriosis
01/2018 - 07/2015
2Ovarian Epithelial Carcinoma
03/2012 - 06/2011
2Aneuploidy (Aneuploid)
01/2010 - 07/2007
1Second Primary Neoplasms (Neoplasms, Second)
09/2022
1Male Breast Neoplasms (Male Breast Cancer)
08/2022
1Brain Neoplasms (Brain Tumor)
01/2022

Drug/Important Bio-Agent (IBA)

67Estrogen ReceptorsIBA
11/2022 - 04/2006
31DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2002
25Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2005
25Hormones (Hormone)IBA
01/2022 - 06/2009
21Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 05/2009
16Biological ProductsIBA
09/2022 - 05/2005
11Biomarkers (Surrogate Marker)IBA
09/2022 - 09/2009
8Estrogens (Estrogen)FDA Link
05/2021 - 05/2009
8Transcription Factors (Transcription Factor)IBA
01/2020 - 09/2009
7Phenobarbital (Luminal)FDA Link
06/2022 - 02/2016
7RNA (Ribonucleic Acid)IBA
10/2021 - 07/2004
7TamoxifenFDA LinkGeneric
01/2020 - 12/2005
6human ERBB2 proteinIBA
01/2022 - 01/2015
6MicroRNAs (MicroRNA)IBA
10/2021 - 06/2011
6AnthracyclinesIBA
07/2021 - 01/2014
6ORALIT (ORS)IBA
12/2020 - 05/2009
6Messenger RNA (mRNA)IBA
09/2017 - 05/2003
5NucleotidesIBA
11/2022 - 02/2008
53' Untranslated Regions (3' UTR)IBA
11/2016 - 03/2007
4Genetic Markers (Genetic Marker)IBA
09/2022 - 09/2009
4mahuang-tangIBA
01/2022 - 04/2013
4ParaffinIBA
10/2021 - 12/2005
4ErbB Receptors (EGF Receptor)IBA
05/2021 - 05/2010
4PlatinumIBA
03/2021 - 08/2009
4Epidermal Growth Factor (EGF)IBA
01/2021 - 05/2010
4Cisplatin (Platino)FDA LinkGeneric
03/2013 - 12/2006
3Pharmaceutical PreparationsIBA
06/2022 - 06/2012
3taxaneIBA
03/2021 - 01/2018
3Phosphotransferases (Kinase)IBA
01/2021 - 01/2010
3A-Form DNA (A-DNA)IBA
12/2019 - 09/2012
3ChromatinIBA
01/2016 - 01/2015
3BRCA1 ProteinIBA
01/2016 - 06/2004
3Histones (Histone)IBA
07/2015 - 01/2010
3Cytochrome P-450 CYP2D6 (CYP2D6)IBA
09/2008 - 12/2005
2Adenosine Monophosphate (AMP)IBA
01/2022 - 01/2021
2Formaldehyde (Formol)FDA Link
10/2021 - 03/2017
2InterferonsIBA
10/2021 - 09/2017
2Galectin 3 (LGALS3)IBA
07/2021 - 12/2008
2Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2021 - 10/2016
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021 - 07/2011
2Gonadal Steroid Hormones (Sex Hormones)IBA
01/2021 - 11/2015
2olaparibIBA
01/2021 - 01/2019
2Cadherins (E-Cadherin)IBA
01/2018 - 10/2016
2Tumor Biomarkers (Tumor Markers)IBA
11/2017 - 02/2011
2Transforming Growth Factors (Transforming Growth Factor)IBA
09/2017 - 05/2009
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2017 - 05/2003
2Codon (Codons)IBA
02/2016 - 05/2005
2Transforming Growth Factor-beta Type II ReceptorIBA
01/2016 - 02/2015
2Nonsense Codon (Nonsense Mutation)IBA
09/2015 - 10/2014
2LuciferasesIBA
07/2015 - 04/2013
2Complement System Proteins (Complement)IBA
01/2015 - 07/2011
2P-2 (P 2)IBA
01/2015 - 02/2011
2Aurora Kinase AIBA
01/2015 - 07/2007
2Selective Estrogen Receptor Modulators (SERM)IBA
01/2015 - 10/2014
2Cytochrome P-450 CYP3AIBA
05/2014 - 12/2005
2EnzymesIBA
01/2014 - 01/2007
2Transforming Growth Factor beta (TGF-beta)IBA
01/2010 - 05/2009
2beta CateninIBA
09/2009 - 08/2008
2Interleukin-17 (Interleukin 17)IBA
09/2008 - 04/2006
2Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2006 - 04/2005
1Androgen Receptors (Androgen Receptor)IBA
06/2022
1Estrogen Receptor betaIBA
02/2022
1Blood Group Antigens (Blood Groups)IBA
01/2022

Therapy/Procedure

28Therapeutics
06/2022 - 07/2005
15Drug Therapy (Chemotherapy)
07/2021 - 04/2013
4Radiotherapy
01/2020 - 12/2015
4Lasers (Laser)
01/2018 - 11/2013
4Adjuvant Chemotherapy
01/2018 - 02/2015
4Salpingo-oophorectomy
11/2017 - 09/2010
3Neoadjuvant Therapy
06/2022 - 01/2018
3Mastectomy (Mammectomy)
10/2016 - 09/2010
2Aftercare (After-Treatment)
08/2022 - 01/2021
1Ovariectomy (Oophorectomy)
01/2022